The association of intolerance to non-steroidal anti-inflammatory drugs, bronchial asthma and nasal polyps: Clinical aspects and treatment strategies in Poland
Keywords:
allergy, desensitization, diagnostic markers, hypersensitivity, pharmacotherapyAbstract
Objective: To investigate the correlation between intolerance to non-steroidal anti-inflammatory drugs (NSAIDs), bronchial asthma, and nasal polyps, and to develop an effective treatment strategy for patients suffering from these conditions simultaneously.
Methods: The study was conducted across several clinical centres and included 200 patients diagnosed with bronchial asthma and nasal polyps, as well as intolerance to NSAIDs. Data were collected on the clinical manifestations of the pathology, including disease symptoms, frequency, and severity of exacerbations, along with their allergic history and tolerance to various drugs. Additionally, laboratory tests were performed, including blood tests to determine eosinophil levels, immunoglobulin E, and other inflammatory markers.
Results: Based on the collected data, individualized treatment regimens were developed, combining pharmacotherapy and methods of desensitization to NSAIDs. Pharmacotherapy included the use of inhaled corticosteroids to reduce airway inflammation, antihistamines to control allergic symptoms, and monoclonal antibodies to modify the immune response. Desensitization methods involved the gradual introduction of NSAIDs under strict medical supervision, which helped to increase tolerance to these drugs.
Conclusions: This comprehensive and individualized approach significantly improved patients’ quality of life, reducing the frequency and severity of exacerbations, improving lung function, and overall well-being. This study emphasizes the importance of a comprehensive approach to the diagnosis and treatment of patients with intolerance to NSAIDs, bronchial asthma, and nasal polyps, and the need for further research in this area.
Downloads
References
1. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence [Internet]. J Allergy Clin Immunol. 2020; 145(1):70-80. DOI: https://doi.org/10.1016/j.jaci.2019.06.049
2. Pawankar R, Nagata M. Asia pacific association of allergy asthma and clinical immunology and workshop on eosinophils in allergy and related diseases [Internet]. Asia Pac Allergy. 2020; 10(2):e23. DOI: https://doi.org/10.5415/apallergy.2020.10.e23
3. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma [Internet]. Lancet. 2018; 391(10122):783-800. DOI: https://doi.org/10.1016/s0140-6736(17)33311-1
4. Ryu G, Bae J-S, Kim JH, Kim EH, Lyu L, Chung Y-J, et al. Role of IL-17A in chronic rhinosinusitis with nasal polyp [Internet]. Allergy, Asthma Immunol Res. 2020; 12(3):507-522. DOI: https://doi.org/10.4168/aair.2020.12.3.507
5. Weiss SL, Smith DM. A case of serum sickness-like reaction in an adult treated with omalizumab [Internet]. Mil Med. 2020; 185(5-6):912-913. DOI: https://doi.org/10.1093/milmed/usz357
6. Khan DA, Banerji A, Blumenthal KG, Phillips EJ, Solensky R, White AA, el al. Drug allergy: A 2022 practice parameter update [Internet]. J Allergy Clin Immunol. 2022; 150(6):1333-1393. DOI: https://doi.org/10.1016/j.jaci.2022.08.028
7. Diver S, Russell RJ, Brightling CE. New and emerging drug treatments for severe asthma [Internet]. Clin Exp Allergy. 2018; 48(3):241-252. DOI: https://doi.org/10.1111/cea.13086
8. Hansbro NG, Horvat JC, Wark PA, Hansbroa PM. Understanding the mechanisms of viral induced asthma: New therapeutic directions [Internet]. Pharmacol Ther. 2008; 117(3):313-353. DOI: https://doi.org/10.1016/j.pharmthera.2007.11.002
9. Diamant Z, van Maaren M, Muraro A, Jesenak M, Striz I. Allergen immunotherapy for allergic asthma: The future seems bright [Internet]. Respir Med. 2023; 210:107125. DOI: https://doi.org/10.1016/j.rmed.2023.107125
10. Pawankar R, Canonica GW, Holgate ST, Lockey RF. Allergic diseases and asthma: A major global health concern [Internet]. Curr Opin Allergy Clin Immunol. 2012; 12(1):39-41. DOI: https://doi.org/10.1097/aci.0b013e32834ec13b
11. Cheng S-L. Immunologic pathophysiology and airway remodeling mechanism in severe asthma: Focused on IgE-mediated pathways [Internet]. Diagnostics. 2021; 11(1):83. DOI: https://doi.org/10.3390/diagnostics11010083
12. Woo S-D, Yang E-M, Jang J, Lee Y, Shin YS, Ye Y-M, et al. Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma [Internet]. Ann Allergy, Asthma, Immunol. 2021; 127(1):109-115. DOI: https://doi.org/10.1016/j.anai.2021.03.023
13. Wellmann N, Marc MS, Stoicescu ER, Pescaru CC, Trusculescu AA, Martis FG, et al. Enhancing adult asthma management: A review on the utility of remote home spirometry and mobile applications [Internet]. J Pers Med. 2024; 14(8):852. DOI: https://doi.org/10.3390/jpm14080852
14. Galant SP, Morphew T. Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, and potential targeted therapy [Internet]. Ann Allergy, Asthma, Immunol. 2024; 132(1):21-29. DOI: https://doi.org/10.1016/j.anai.2023.08.011
15. Burchett JR, Dailey JM, Kee SA, Pryor DT, Kotha A, Kankaria RA, et al. Targeting mast cells in allergic disease: Current therapies and drug repurposing [Internet]. Cells. 2022; 11(19):3031. DOI: https://doi.org/10.3390/cells11193031
16. Chacón P, Vega‐Rioja A, Doukkali B, del Valle Rodríguez A, Bellido V, Puente Y, et al. Targeted inhibition of allergen‐induced histamine production by neutrophils [Internet]. Fed Am Soc Exp Biol J. 2021; 35(5):e21483. DOI: https://doi.org/10.1096/fj.202001912R
17. Kotoulas SC, Tsiouprou I, Fouka E, Pataka A, Papakosta D, Porpodis K. Omalizumab: An optimal choice for patients with severe allergic asthma [Internet]. J Pers Med. 2022; 12(2):165. DOI: https://doi.org/10.3390/jpm12020165
18. Gon Y, Maruoka S, Mizumura K. Omalizumab and IgE in the control of severe allergic asthma [Internet]. Front Pharmacol. 2022; 13:839011. DOI: https://doi.org/10.3389/fphar.2022.839011
19. Hammad H, Lambrecht BN. The basic immunology of asthma [Internet]. Cell. 2021; 184(6):1469-85. DOI: https://doi.org/10.1016/j.cell.2021.02.016
20. Dastghaib S, Kumar PS, Aftabi S, Damera G, Dalvand A, Sepanjnia A, et al. Mechanisms targeting the unfolded protein response in asthma [Internet]. Am J Respir Cell Mol Biol. 2021; 64(1):29-38. DOI: https://doi.org/10.1165/rcmb.2019-0235TR
21. Pavón-Romero GF, Parra-Vargas MI, Ramírez-Jiménez F, Melgoza-Ruiz E, Serrano-Pérez NH, Teran LM. Allergen immunotherapy: Current and future trends [Internet]. Cells. 2022; 11(2):212. DOI: https://doi.org/10.3390/cells11020212
22. Hulett AC, Novo MJS, Martínez J, García ME, Rodríguez C, Torres J, et al. Asthma in Venezuela: An epidemiological narrative [Internet]. Gac Med Carac. 2025; 133(1):263-271. DOI: https://doi.org/10.47307/GMC.2025.133.1.24
23. Lambrecht BN, Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis [Internet]. Nat Immunol. 2017; 18(10):1076-1083. DOI: https://doi.org/10.1038/ni.3829
24. Tyler MA, Luong AU. Current understanding of allergic fungal rhinosinusitis [Internet]. World J Otorhinolaryngol Head Neck Surg. 2018; 4(3):179-185. DOI: https://doi.org/10.1016/j.wjorl.2018.08.003
25. Van Wicklin SA. Safe and Effective Use of Local Anesthetics [Internet]. Plast Aesthetic Nurs. 2024; 44(3):172-179. DOI: https://doi.org/10.1097/PSN.0000000000000580
26. Ismailov I, Kılınç N, Magarde BK, Musheer M, Ahmad S. A systematic review of the role of surfactants in bronchial asthma: Implications for pathogenesis and treatment of the disease [Internet]. Gac Med Carac. 2024; 132:S152-S159. DOI: https://doi.org/10.47307/gmc.2024.132.s1.20
27. Yermukhanova LS, Urazaeva S, Artukbaeva M, Azhenova K, Almakhanova M, Zhaubassova A, et al. Determination of the air pollution index of atmospheric air in Aktobe [Internet]. Ann Trop Med Publ Health. 2017; 10(3):664-666. DOI: https://doi.org/10.4103/ATMPH.ATMPH_209_17
28. Kardas G, Panek M, Kuna P, Damiański P, Kupczyk M. Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives [Internet]. Front Immunol. 2022; 13:983852. DOI: https://doi.org/10.3389/fimmu.2022.983852
29. Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology [Internet]. J Allergy Clin Immunol [access: 07/12/2024]. 2020; 145(3):775-793. Available from: https://pubmed.ncbi.nlm.nih.gov/23587334/
30. Hartmane I, Ivdra I, Mikazans I, Bondare-Ansberga V. Immunopathogenic Treatment Options for Psoriasis Patients under a Restrictive Reimbursement Environment [Internet]. Proceed Latv Acad Sci Sect B Nat Exact Appl Sci. 2021; 75(3):158-166. DOI: https://doi.org/10.2478/prolas-2021-0025
31. Pashkovska O. ABCD Classification of Skin Types [Internet]. Plast Aesthetic Nurs. 2024; 44(3):188-199. DOI: https://doi.org/10.1097/PSN.0000000000000567
32. Hartmane I, Mikaþâns I, Ivdra I, Bondare-Ansberga V, Teterina I, Bataraga E. Retrospective cohort study comparing efficacy and safety of pharmacological intervention and phototherapy in moderate to severe psoriasis patients in a real-world setting [Internet]. Proceed Latv Acad Sci Sect B Nat Exact Appl Sci. 2024; 78(2):141-146. DOI: https://doi.org/10.2478/prolas-2024-0021
33. Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: Striking the balance between efficacy and safety [Internet]. Eur Respir Rev. 2020; 29(155):190151. DOI: https://doi.org/10.1183/16000617.0151-2019
34. Zasorin BV, Kurmangaliev OM, Ermukhanova LS. Features of the immune status in the population of urban areas with a high content of heavy metals [Internet]. Gig Sanit [access: 02/11/2024]. 2012; 3:17-19. Available from: https://pubmed.ncbi.nlm.nih.gov/23088112/
35. Balayeva EZ, Suleymanov TA, Hanaee J, Jouyban A. Liquid chromatographic determination of thymol in a pharmaceutical formulation [Internet]. Latin Amer J Pharm [access: 07/09/2024]. 2020; 39(8):1509-1514. Available from: https://www.researchgate.net/publication/353212213
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Maria Zofia Lisiecka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
